Vilobelimab’s effect on mortality in severe COVID-19 ARDS patients: Phase 3 RCT
Alexander Vlaar, Endry Lim, Djillali Annane, Martin Witzenrath, Michael Bauer, Leo Heunks, Bruno Mourvillier, Vasquez Luis Hercilla, Tobias Welte, Pieter Van Paassen, Sanne De Bruin, Matthijs Brouwer, Pieter Tuinman, Jose Saraiva, Marx Gernot, Suzana Lobo, Rodrigo Boldo, Jesus Simon-Campos, Alexander Cornet, Anastasia Grebenyuk, Johannes Engelbrecht, Maria Habel, Claus Thielert, James Dickinson, Bruce Burnett, Simon Ruckinger, Robert Zerbib, Dorothee Neukirchen, Renfeng Guo, Diederik Van De Beek, Niels Riedemann
European Respiratory Journal Sep 2023, 62 (suppl 67) OA786; DOI: 10.1183/13993003.congress-2023.OA786